New molecular markers have been recently identified for supratentorial ependymoma (SE), particularly RELA rearrangements coding for a protein of the NFκB complex. In this study we compared different techniques (FISH, immunohistochemistry (IHC) and DNA methyloma analysis (DNAm)) in the assessment of RELA rearrangements and their correlation with clinical and histological characteristics in a series of 41 pediatric supratentorial ependymoma. Break apart probes for C11orf95 and RELA were developed, NFκB pathway activation having also been analyzed by IHC and DNAm. NFκB IHC and FISH for RELA were positive in 56% (23/41) and 68% (21/31) cases with 96% concordance. Sixty three percent (24/38) cases were RELA- positive by DNAm showing 87% concordance with IHC (33/38) and FISH (27/31). Two cases showed YAP rearrangements and favorable outcome. Twelve tumors clustered apart from SE, and were reclassified by DNAm: 4 subependymoma, 6 PNET, 1 histone H3.3 mutated glioma and 1 infratentorial ependymoma. All patients with tumors reclassified as subependymoma had a favorable outcome despite histological signs of malignancy, and should probably not be graded with classic histological criteria of malignancy. In conclusion FISH and IHC are useful for the diagnosis of SE. DNAm reclassifies a significant proportion of histological ependymoma and highlights a group of tumors (“PNET”) displaying ependymal differentiation and frequent 16q and 22q chromosomal alterations, which should be better characterized in larger collaborative series.
. 2016 May 30;18(Suppl 3):iii32. doi: 10.1093/neuonc/now070.11
EPN-12: PEDIATRIC SUPRATENTORIAL EPENDYMOMA: COMPARISON BETWEEN IMMUNOHISTOCHEMISTRY, FISH AND DNA METHYLATION ANALYSIS FOR RELA REARRANGEMENT AND HISTOLOGICAL CORRELATION
Melanie Pagès
1,2, Kristian Pajtler
3, David Castel
4,5, Stephanie Puget
2,6, Christian Sainte-Rose
2,6, Emmanuele Lechapt-Zalcman
1, Marcel Kool
3, David Capper
7, Fabrice Chrétien
1,8, Stefan Pfister
3, Jacques Grill
5,9, Pascale Varlet
1,2, Felipe Andreiuolo
1
Melanie Pagès
1Department of Neuropathology, Sainte-Anne Hospital, Paris, France
2Paris 5 Descartes University, Paris, France
Find articles by Melanie Pagès
Kristian Pajtler
3Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
Find articles by Kristian Pajtler
David Castel
4University Paris-Sud, UMR8203, Villejuif, France
5Gustave Roussy, CNRS UMR8203, Villejuif, France
Find articles by David Castel
Stephanie Puget
2Paris 5 Descartes University, Paris, France
6Departement of Pediatric Neurosurgery, Necker Enfants Malades Hospital, Paris, France
Find articles by Stephanie Puget
Christian Sainte-Rose
2Paris 5 Descartes University, Paris, France
6Departement of Pediatric Neurosurgery, Necker Enfants Malades Hospital, Paris, France
Find articles by Christian Sainte-Rose
Emmanuele Lechapt-Zalcman
1Department of Neuropathology, Sainte-Anne Hospital, Paris, France
Find articles by Emmanuele Lechapt-Zalcman
Marcel Kool
3Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
Find articles by Marcel Kool
David Capper
7Department of Neuropathology, University of Heidelberg, Heidelberg, Germany
Find articles by David Capper
Fabrice Chrétien
1Department of Neuropathology, Sainte-Anne Hospital, Paris, France
8Histopathology and Animal Models, Pasteur Institute, Paris, France
Find articles by Fabrice Chrétien
Stefan Pfister
3Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
Find articles by Stefan Pfister
Jacques Grill
5Gustave Roussy, CNRS UMR8203, Villejuif, France
9Department of Pediatric Oncology, Gustave Roussy, Villejuif, France
Find articles by Jacques Grill
Pascale Varlet
1Department of Neuropathology, Sainte-Anne Hospital, Paris, France
2Paris 5 Descartes University, Paris, France
Find articles by Pascale Varlet
Felipe Andreiuolo
1Department of Neuropathology, Sainte-Anne Hospital, Paris, France
Find articles by Felipe Andreiuolo
1Department of Neuropathology, Sainte-Anne Hospital, Paris, France
2Paris 5 Descartes University, Paris, France
3Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
4University Paris-Sud, UMR8203, Villejuif, France
5Gustave Roussy, CNRS UMR8203, Villejuif, France
6Departement of Pediatric Neurosurgery, Necker Enfants Malades Hospital, Paris, France
7Department of Neuropathology, University of Heidelberg, Heidelberg, Germany
8Histopathology and Animal Models, Pasteur Institute, Paris, France
9Department of Pediatric Oncology, Gustave Roussy, Villejuif, France
Issue date 2016 Jun.
© the author(s) 2016. published by oxford university press on behalf of the society for neuro-oncology. all rights reserved. for permissions, please e-mail: journals.permissions@oup.com
PMCID: PMC4903296
